ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00291850
Recruitment Status : Terminated (no patient recruitment)
First Posted : February 15, 2006
Last Update Posted : May 1, 2012
Sponsor:
Information provided by (Responsible Party):
Central European Cooperative Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : No date given